104 related articles for article (PubMed ID: 12934112)
1. Analysis of 14-3-3sigma expression in hyperproliferative skin diseases reveals selective loss associated with CpG-methylation in basal cell carcinoma.
Lodygin D; Yazdi AS; Sander CA; Herzinger T; Hermeking H
Oncogene; 2003 Aug; 22(35):5519-24. PubMed ID: 12934112
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer is characterized by epigenetic silencing of 14-3-3sigma expression.
Lodygin D; Diebold J; Hermeking H
Oncogene; 2004 Dec; 23(56):9034-41. PubMed ID: 15489902
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic inactivation of 14-3-3 sigma in oral carcinoma: association with p16(INK4a) silencing and human papillomavirus negativity.
Gasco M; Bell AK; Heath V; Sullivan A; Smith P; Hiller L; Yulug I; Numico G; Merlano M; Farrell PJ; Tavassoli M; Gusterson B; Crook T
Cancer Res; 2002 Apr; 62(7):2072-6. PubMed ID: 11929827
[TBL] [Abstract][Full Text] [Related]
4. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
Lodygin D; Hermeking H
Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
[TBL] [Abstract][Full Text] [Related]
5. Coincident inactivation of 14-3-3sigma and p16INK4a is an early event in vulval squamous neoplasia.
Gasco M; Sullivan A; Repellin C; Brooks L; Farrell PJ; Tidy JA; Dunne B; Gusterson B; Evans DJ; Crook T
Oncogene; 2002 Mar; 21(12):1876-81. PubMed ID: 11896620
[TBL] [Abstract][Full Text] [Related]
6. 14-3-3sigma is down-regulated in human prostate cancer.
Urano T; Takahashi S; Suzuki T; Fujimura T; Fujita M; Kumagai J; Horie-Inoue K; Sasano H; Kitamura T; Ouchi Y; Inoue S
Biochem Biophys Res Commun; 2004 Jul; 319(3):795-800. PubMed ID: 15184053
[TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of 14-3-3sigma in cancer.
Lodygin D; Hermeking H
Semin Cancer Biol; 2006 Jun; 16(3):214-24. PubMed ID: 16698281
[TBL] [Abstract][Full Text] [Related]
8. Expression profiles of p63, p53, survivin, and hTERT in skin tumors.
Park HR; Min SK; Cho HD; Kim KH; Shin HS; Park YE
J Cutan Pathol; 2004 Sep; 31(8):544-9. PubMed ID: 15268709
[TBL] [Abstract][Full Text] [Related]
9. Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potential.
Yatabe Y; Osada H; Tatematsu Y; Mitsudomi T; Takahashi T
Oncogene; 2002 Nov; 21(54):8310-9. PubMed ID: 12447694
[TBL] [Abstract][Full Text] [Related]
10. The expression of p63 and p53 in keratoacanthoma and intraepidermal and invasive neoplasms of the skin.
Sakiz D; Turkmenoglu TT; Kabukcuoglu F
Pathol Res Pract; 2009; 205(9):589-94. PubMed ID: 19577853
[TBL] [Abstract][Full Text] [Related]
11. 14-3-3sigma expression and prognostic value in patients with epithelial ovarian carcinoma: a high throughput tissue microarray analysis.
Mhawech-Fauceglia P; Herrmann FR; Andrews C; South S; Beck A; Lele S; Odunsi K
Eur J Surg Oncol; 2009 Jul; 35(7):763-7. PubMed ID: 19081223
[TBL] [Abstract][Full Text] [Related]
12. Radiation response and cell cycle regulation of p53 rescued malignant keratinocytes.
Niemantsverdriet M; Jongmans W; Backendorf C
Exp Cell Res; 2005 Oct; 310(1):237-47. PubMed ID: 16120440
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of 14-3-3sigma by hypermethylation is a rare event in colorectal cancers and its expression may correlate with cell cycle maintenance at the invasion front.
Ide M; Nakajima T; Asao T; Kuwano H
Cancer Lett; 2004 Apr; 207(2):241-9. PubMed ID: 15072834
[TBL] [Abstract][Full Text] [Related]
14. The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas.
Wang Z; Tropè CG; Suo Z; Trøen G; Yang G; Nesland JM; Holm R
BMC Cancer; 2008 Oct; 8():308. PubMed ID: 18950492
[TBL] [Abstract][Full Text] [Related]
15. Deregulation of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in basal cell carcinoma.
Kanellou P; Zaravinos A; Zioga M; Spandidos DA
Br J Dermatol; 2009 Jun; 160(6):1215-21. PubMed ID: 19298278
[TBL] [Abstract][Full Text] [Related]
16. p16(INK4a) promoter methylation and 9p21 allelic loss in colorectal carcinomas: relation with immunohistochemical p16(INK4a) expression and with tumor budding.
Prall F; Ostwald C; Weirich V; Nizze H
Hum Pathol; 2006 May; 37(5):578-85. PubMed ID: 16647956
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of 14-3-3 sigma protein in various histological subtypes of uterine cervical cancers.
Sano T; Shimooka H; Weixa P; Segawa A; Jian Z; Motegi A; Nakayama H; Oyama T; Nakajima T
Pathol Int; 2004 Oct; 54(10):743-50. PubMed ID: 15482563
[TBL] [Abstract][Full Text] [Related]
18. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
Okumura H; Natsugoe S; Matsumoto M; Yokomakura N; Uchikado Y; Takatori H; Ishigami S; Takao S; Aikou T
J Surg Oncol; 2005 Jul; 91(1):84-9. PubMed ID: 15999354
[TBL] [Abstract][Full Text] [Related]
19. Gene expression and methylation status of 14-3-3sigma in human renal carcinoma tissues.
Liang S; Xu Y; Shen G; Zhao X; Zhou J; Li X; Gong F; Ling B; Fang L; Huang C; Wei Y
IUBMB Life; 2008 Aug; 60(8):534-40. PubMed ID: 18548556
[TBL] [Abstract][Full Text] [Related]
20. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance.
Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M
Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
